20 articles by Joe Cantlupe

• Amgen invests in Israeli digital health incubator

  Oct. 26, 2016

• NCPA: FDA to blame for EpiPen price hikes

  Oct. 26, 2016

• Combos remain focus for Vertex as it continues to flounder

  Oct. 26, 2016

• New patient population means new life for AD drug

  Oct. 25, 2016

• BI tapping real-world data for Pradaxa

  Oct. 24, 2016

• Capitol Hill hit parade: Ariad's $199K drug makes list

  Oct. 24, 2016

• Allegro sees success in Luminate eye drug trial

  Oct. 14, 2016

• TG Therapeutics takes stock hit amid trial changes

  Oct. 14, 2016

• Intellipharmaceutics and Mallinckrodt ink CNS deal

  Oct. 13, 2016

• Biotrial opens North American HQ, has successful audit

  Oct. 13, 2016

• Amag takes aim at label extensions

  Oct. 13, 2016

• Next stop in AstraZeneca fire sale: China

  Oct. 13, 2016

• Biocompatibles settles DOJ marketing probe

  Oct. 12, 2016

• Verily, 3M team up to measure healthcare costs

  Oct. 12, 2016

• Merck KGaA, Pfizer and Transgene team up on cancer vaccine

  Oct. 12, 2016

• Swiss Auris aims to bounce back from trial miss

  Oct. 12, 2016

• FDA hits Nicox with CRL on eye drug application

  Oct. 11, 2016

• Exelixis touts kidney cancer drug at ESMO

  Oct. 11, 2016

• Tesaro shakes up PARP battle at ESMO

  Oct. 10, 2016

• Novartis' breast cancer drug scores big at ESMO

  Oct. 10, 2016